Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's "Act Now" Philosophy Has Drawbacks For Industry - CHPA Exec

Related Content

FDA Uses "Unusual" Action To Get Matrixx's Zicam Off The Market

Jun 29 2009

Zicam Case Shows FDA Takes Defining Adverse Events Seriously

Jun 22 2009

Additional Topics

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window